اخبار و اعلانات

 آمار

تعداد نشریات286
تعداد نشریات سازمان84
تعداد شماره‌ها3,012
تعداد مقالات33,669
تعداد مشاهده مقاله44,771,777
تعداد دریافت فایل اصل مقاله39,084,915
Cheraghi, Mostafa, Hashemzadeh, Pejman, Sedighi, Mehrnoosh, Shakarami, Amir. (1403). The Role of Natural Antioxidants on Heart Diseases: A Review Article. سامانه مدیریت نشریات علمی, 13(Special), 726-740. doi: 10.22034/jmpb.2024.366010.1703
Mostafa Cheraghi; Pejman Hashemzadeh; Mehrnoosh Sedighi; Amir Shakarami. "The Role of Natural Antioxidants on Heart Diseases: A Review Article". سامانه مدیریت نشریات علمی, 13, Special, 1403, 726-740. doi: 10.22034/jmpb.2024.366010.1703
Cheraghi, Mostafa, Hashemzadeh, Pejman, Sedighi, Mehrnoosh, Shakarami, Amir. (1403). 'The Role of Natural Antioxidants on Heart Diseases: A Review Article', سامانه مدیریت نشریات علمی, 13(Special), pp. 726-740. doi: 10.22034/jmpb.2024.366010.1703
Cheraghi, Mostafa, Hashemzadeh, Pejman, Sedighi, Mehrnoosh, Shakarami, Amir. The Role of Natural Antioxidants on Heart Diseases: A Review Article. سامانه مدیریت نشریات علمی, 1403; 13(Special): 726-740. doi: 10.22034/jmpb.2024.366010.1703

The Role of Natural Antioxidants on Heart Diseases: A Review Article

Journal of Medicinal plants and By-products
مقاله 2، دوره 13، Special، بهمن 2024، صفحه 726-740    اصل مقاله (983.55 K)
نوع مقاله: Research Paper
شناسه دیجیتال (DOI): 10.22034/jmpb.2024.366010.1703
نویسندگان
Mostafa Cheraghi1؛ Pejman Hashemzadeh2؛ Mehrnoosh Sedighi* 1؛ Amir Shakarami3
1Cardiovascular Research Center, Shahid Rahimi Hospital, Lorestan University of Medical Sciences, Khorramabad, Iran
2Department of Medical Biotechnology, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
3Interventional cardiologists, Department of Cardiology, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
چکیده
Reactive oxygen species and oxidants cause cell damage. Antioxidants are compounds that neutralize reactive oxygen species and protect body structures against these factors. Some enzyme antioxidants such as superoxide dismutase and catalase are naturally present in the body and some are derived from people's habits and diet. Research shows that the main cause of cardiovascular diseases in a pro-inflammatory state is excessive production of reactive oxygen species and irregular levels of plasma lipids. Antioxidants are among the most important molecules in preventing cardiovascular diseases, and inhibiting the oxidation of other molecules is one of the important capabilities of antioxidants. In this study, oxidative stress and the state of antioxidant defense are addressed as the most important mechanisms involved in preventing heart diseases. Related articles published in this research between 1987 and 2024 were used from Google Scholar, PubMed, Web of Science and Scopus scientific databases using the terms antioxidant, oxidative stress, free radicals, and heart diseases. The effects of tocopherol, flavonoids, phenols, carotenoids, lycopene, and vitamin C antioxidants in heart diseases have been investigated. The present research states that reactive oxygen species or oxidants react in free form or in combination with the vital components of the cell and cause serious oxidative damage. These damages become a prelude to many heart diseases. Therefore, antioxidants are useful compounds that neutralize reactive oxygen species but care must be taken in how they are used.
کلیدواژه‌ها
Antioxidants؛ Oxidation؛ Free radicals؛ Heart diseases
مراجع
  1. Rivas-Garcia L., Quintana-Navarro G.M., Torres-Peña J.D., Arenas-de Larriva A.P., Alcala-Díaz J.F., Yubero-Serrano E.M., et al. Dietary antioxidant intake reduces carotid intima-media thickness in coronary heart disease patients: From the CORDIOPREV study. Free Radical Biology and Med. 2024;210:221-9.
  2. Sedighi M., Faghihi M., Rafieian-Kopaei M., Rasoulian B., Nazari A. Cardioprotective Effect of Ethanolic Leaf Extract of Melissa Officinalis L Against Regional Ischemia-Induced Arrhythmia and Heart Injury after Five Days of Reperfusion in Rats. Iran J Pharm Res. 2019;18(3):1530-42.
  3. Qaddoori H.T., Hussain O., Allawi B.I., Hussain A., Allawi R.I. Antioxidant Activity and Heart Diseases. Int J Med Sci Clin Res Stud. 2023;3(07):1432-9.
  4. Tehrani-Banihashemi A., Moradi-Lakeh M., Bcheraoui C., Charara R., Khalil I., Afshin A., et al. Burden of cardiovascular diseases in the Eastern Mediterranean Region, 1990–2015: findings from the Global Burden of Disease 2015 study. Int J Public Health. 2018:137-49.
  5. Mazloumi E., Poorolajal J., Sarrafzadegan N., Roohafza H.R., Faradmal J., Karami M. Avoidable burden of cardiovascular diseases in the eastern Mediterranean region: contribution of selected risk factors for cardiovascular-related deaths. High Blood Press Cardiovasc Prev. 2019;26:227-37.
  6. Sacks F.M., Lichtenstein A.H., Wu J.H., Appel L.J., Creager M.A., Kris-Etherton P.M., et al. Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association. Circulation. 2017;136(3): 1-23.
  7. Mandal I., Sairam N. Accurate prediction of coronary artery disease using reliable diagnosis system. J Med Syst. 2012;36(5):3353-73.
  8. Kohi F., Salehinia H., Mohammadian-Hafshejani A. Trends in mortality from cardiovascular disease in Iran from 2006-2010. J Sabzevar Univ Med Sci. 2015;22(4):630-8.
  9. Dehghani M., Hashemzadeh P., Cheraghi M., Nazari A., Sedighi M. Effects of Medicinal Plants and Secondary Metabolites on the Most Important Risk Factors of Cardiovascular Diseases: A Review. J Med Plants By-prod. 2023;12(4):481-93.
  10. Sedighi M., Seidi H., Asadi F., Biranvand H., Banaei P., Torkashvand M., et al. Cardioprotective effect of dichloromethane valerian (Valeriana OFFICINALIS) Extract on ischemia-reperfusion-induced Cardiac Injuries in rats. Acta Endocrinol (Buchar). 2023;19(2):178-86
  11. Halliwell B. Understanding mechanisms of antioxidant action in health and disease. Nat Rev Mol Cell Biol
  12. .. 2024;25(1):13-33.
  13. Sies H., Berndt C., Jones D. Oxidative stress. Annu. Rev. Biochem. 2017;86:715-48.
  14. Mohammadian K., Fakhar F., Keramat S., Stanek A. The Role of Antioxidants in the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review. Antioxidants. 2024;13(7):797.
  15. Cushnie B., Jaruchotikamol A., Laihakhot J., Chotson A. In vitro antiglycation and antioxidant properties of ethanolic extracts of Ficus botryocarpa and Ficus racemosa fruits. J Herbmed Pharmacol. 2024;13(3):472-81.
  16. Dhammaraj T., Kotseekieo P., Chotikarn T., Phosrithong N., Praison W., Prasomsub T., et al. In vitro investigation of xanthine oxidase inhibitory and antioxidant activities of 3, 4, 5-trihydroxycinnamic acid. J Herbmed Pharmacol. 2024;13(3):439-49.
  17. Eloh K., Koza B., Simalou O., Sanvee S.C.J., Bakaï M.F. Phytochemical analysis, antioxidant potential, and in vitro antidiabetic activity of Grewia lasiodiscus (K Schum) leaves extract. 2024;13(1):129-36.
  18. Zakhour R., El-Guourrami O., Bouothmany K., Ftouh S., Benkhouili F.Z., Benzeid H., et al. Antioxidant, photoprotective, cytotoxic, and antimicrobial activities of Albuca amoena Batt. J Herbmed Pharmacol. 2024;13(1):101-10.
  19. Pinilla-González V., Rojas-Solé C., Gómez-Hevia F., González-Fernández T., Cereceda-Cornejo A., Chichiarelli S., et al. Tapping into Nature’s Arsenal: Harnessing the Potential of Natural Antioxidants for Human Health and Disease Prevention. Foods. 2024;13(13):1999.
  20. Ruberto G., Baratta M.T. Antioxidant activity of selected essential oil components in two lipid model systems. Food chemistry. 2000;69(2):167-74.
  21. Moure A., Cruz J.M., Franco D., Domı́nguez J.M., Sineiro J., Domı́nguez H., et al. Natural antioxidants from residual sources. Food chemistry. 2001;72(2):145-71.
  22. Puangploy P., Kittipongpittaya K., Khoontawad J., Jorjong S., Phalangsuk N., Phansuwan T., et al. Phytochemical screening, total phenolics, total flavonoids, total tannins, antioxidant activities, and α-glucosidase inhibition of ethanolic leaf extracts from 37 cultivars of Antidesma puncticulatum Miq. J Herbmed Pharmacol. 2024;13(1):61-73.
  23. Arya A., Kumar S., Kain D., Vandana V., Mikawlrawng K. Metabolite profiling, antioxidant, antibacterial, and carbohydrate hydrolyzing enzyme inhibition activities of Drymaria cordata. J Herbmed Pharmacol. 2024;13(3):407-19.
  24. Rao L.G., Guns E., Rao A.V. Lycopene: Its role in human health and disease. Agro Food. 2003;7:25-30.
  25. Mohammed F.S., Akgul H., Sevindik M., Khaled B.M.T. Phenolic content and biological activities of Rhus coriaria var. zebaria. Fresenius Environ Bull. 2018;27(8):5694-702.
  26. Opatrilova R., Kubatka P., Caprnda M., Büsselberg D., Krasnik V., Vesely P., et al. Nitric oxide in the pathophysiology of retinopathy: evidences from preclinical and clinical researches. Acta Ophthalmologica. 2018;96(3):222-31.
  27. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685-95.
  28. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135-43.
  29. Fuchs D., Avanzas P., Arroyo-Espliguero R., Jenny M., Consuegra-Sanchez L., Kaski J. The role of neopterin in atherogenesis and cardiovascular risk assessment. Curr Med Chem . 2009;16(35):4644-53.
  30. Celec P., Hodosy J., Behuliak M., Pálffy R., Gardlík R., Halčák L., et al. Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure. Sleep Breath . 2012;16:393-8.
  31. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44-84.
  32. Mancuso M., Bonanni E., Logerfo A., Orsucci D., Maestri M., Chico L., et al. Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome. Sleep Med. 2012;13(6):632-6.
  33. Christou K., Moulas A.N., Pastaka C., Gourgoulianis K.I. Antioxidant capacity in obstructive sleep apnea patients. Sleep med. 2003;4(3):225-8.
  34. Yamauchi M., Kimura H. Oxidative stress in obstructive sleep apnea: putative pathways to the cardiovascular complications. Antioxid Redox Signal. 2008;10(4):755-68.
  35. Devasagayam T., Tilak J., Boloor K., Sane K.S., Ghaskadbi S.S., Lele R. Free radicals and antioxidants in human health: current status and future prospects. Japi. 2004;52(794804):794-804.
  36. Riemersma R.A., Wood D.A., Macintyre C., Elton R., Gey K.F., Oliver M.F. Low plasma vitamins E and C. Increased risk of angina in Scottish men. Ann N Y Acad Sci . 1989;570:291-5.
  37. Bjørklund G., Meguid N.A., El-Bana M.A., Tinkov A.A., Saad K., Dadar M., et al. Oxidative stress in autism spectrum disorder. Mol Neurobiol. 2020;57:2314-32.
  38. Caminiti R., Carresi C., Mollace R., Macrì R., Scarano F., Oppedisano F., et al. The potential effect of natural antioxidants on endothelial dysfunction associated with arterial hypertension. Front Cardiovasc Med. 2024;11:1345218.
  39. Krzemińska J., Wronka M., Młynarska E., Franczyk B., Rysz J. Arterial hypertension—Oxidative stress and inflammation. Antioxidants. 2022;11(1):172.
  40. Bagchi K., Puri S. Free radicals and antioxidants in health and disease: A review. EMHJ-Eastern Mediterranean Health Journal. 1998, 4 (2), 350-60.
  41. Liu T., Stern A., Roberts L.J., Morrow J.D. The isoprostanes: novel prostaglandin-like products of the free radical-catalyzed peroxidation of arachidonic acid. J Biomed Sci. 1999;6:226-35.
  42. Halliwell B. How to characterize an antioxidant: an update. Biochemical Society Symposia; 1995: Portland Press Limited. Biochem Soc Symp. 1995:61:73-101
  43. Shi H., Noguchi N., Niki E. Comparative study on dynamics of antioxidative action of α-tocopheryl hydroquinone, ubiquinol, and α-tocopherol against lipid peroxidation. Free Radic Biol Med. 1999;27(3-4):334-46.
  44. Levine M., Rumsey S.C., Daruwala R., Park J.B., Wang Y. Criteria and recommendations for vitamin C intake. JAMA. 1999;281(15):1415-23.
  45. Rice-Evans C.A., Diplock A.T. Current status of antioxidant therapy. Free Radic Biol Med. 1993;15(1):77-96.
  46. Krinsky N.I. Mechanism of action of biological antioxidants. Proc Soc Exp Biol Med. 992;200(2):248-54.
  47. Rolo A.P., Palmeira C.M. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol. 2006;212(2):167-78.
  48. Goncalves A., Amiot M.J. Fat-soluble micronutrients and metabolic syndrome. Curr Opin Clin Nutr Metab Car . 2017;20(6):492-7.
  49. Niki E. Evidence for beneficial effects of vitamin E. Korean J Intern Med. 2015;30(5):571-9.
  50. Martins-Gregório B., Benchimol D.E., Souza D., Amorim de Morais Nascimento F., Matta L., Fernandes-Santos C. The potential role of antioxidants in metabolic syndrome. Curr Pharm Des. 2016;22(7):859-69.
  51. Levy A.P., Blum S. Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E. Expert Rev Cardiovasc Ther. 2007;5(6):1105-11.
  52. Hennekens C.H. Antioxidant vitamins and cardiovascular disease. Antioxidant Status, Diet, Nutrition, and Health: CRC Press; 2019. p. 463-77.
  53. Brigelius-Flohé R. Vitamin E: the shrew waiting to be tamed. Free Radic Biol Med. 2009;46(5):543-54.
  54. Rashidi B., Hoseini Z., Sahebkar A., Mirzaei H. Anti‐atherosclerotic effects of vitamins D and E in suppression of atherogenesis. J Cell Physiol. 2017;232(11):2968-76.
  55. Schubert M., Kluge S., Schmölz L., Wallert M., Galli F., Birringer M., et al. Long-chain metabolites of vitamin E: metabolic activation as a general concept for lipid-soluble vitamins? Antioxidants. 2018;7(1):10.
  56. Mathur P., Ding Z., Saldeen T., Mehta J.L. Tocopherols in the prevention and treatment of atherosclerosis and related cardiovascular disease. Clin Cardiol. 2015;38(9):570-6.
  57. Crozier A., Jaganath I.B., Clifford M.N. Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep. 2009;26(8):1001-43.
  58. Richelle M., Tavazzi I., Offord E. Comparison of the antioxidant activity of commonly consumed polyphenolic beverages (coffee, cocoa, and tea) prepared per cup serving. J Agric Food Chem. 2001;49(7):3438-42.
  59. Prior R.L., Wu X. Anthocyanins: structural characteristics that result in unique metabolic patterns and biological activities. Free Radic Res. 2006;40(10):1014-28.
  60. Li W.G., Zhang X.Y., Wu Y.j., Tian X. Anti-inflammatory effect and mechanism of proanthocyanidins from grape seeds. Acta Pharmacol Sin. 2001;22(12):1117-20.
  61. Williams R.J., Spencer J.P., Rice-Evans C. Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med. 2004;36(7):838-49.
  62. Vita J.A. Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am J Clin Nutr. 2005;81(1):292S-7S.
  63. Stoclet J.C., Chataigneau T., Ndiaye M., Oak M.H., Bedoui J., Chataigneau M., et al. Vascular protection by dietary polyphenols. Eur J Pharmacol. 2004;500(1-3):299-313.
  64. Mulvihill E.E., Huff M.W. Antiatherogenic properties of flavonoids: implications for cardiovascular health. Can J Cardiol 2010;26 Suppl A:17a-21a.
  65. Mendes-Junior L.d.G., Monteiro M.M.d.O., Carvalho A.d.S., Queiroz T.M.d., Braga V.d.A. Oral supplementation with the rutin improves cardiovagal baroreflex sensitivity and vascular reactivity in hypertensive rats. Appl Physiol Nutr Metab. 2013;38(11):1099-106.
  66. Jaffri J.M., Mohamed S., Rohimi N., Ahmad I.N., Noordin M.M., Manap Y.A. Antihypertensive and cardiovascular effects of catechin-rich oil palm (Elaeis guineensis) leaf extract in nitric oxide–deficient rats. J Med Food. 2011;14(7-8):775-83.
  67. Yamamoto M., Suzuki A., Hase T. Short-term effects of glucosyl hesperidin and hesperetin on blood pressure and vascular endothelial function in spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo) 2008;54(1):95-8.
  68. Edge R., Truscott T.G. Singlet oxygen and free radical reactions of retinoids and carotenoids—a review. Antioxidants. 2018;7(1):5.
  69. Kutan-Fenercioglu A., Saler T., Genc E., Sabuncu H., Altuntas Y. The effects of polyphenol-containing antioxidants on oxidative stress and lipid peroxidation in Type 2 diabetes mellitus without complications. J Endocrinol Invest. 2010;33:118-24.
  70. Cheng Y.C., Sheen J.M., Hu W.L., Hung Y.C. Polyphenols and oxidative stress in atherosclerosis‐related ischemic heart disease and stroke. Oxid Med Cell Longe. 2017;2017(1):8526438.
  71. Brito P.M., Devillard R., Nègre-Salvayre A., Almeida L.M., Dinis T.C., Salvayre R., et al. Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells. Atherosclerosis. 2009;205(1):126-34.
  72. Sung M.M., Das S.K., Levasseur J., Byrne N.J., Fung D., Kim T.T., et al. Resveratrol treatment of mice with pressure-overload–induced heart failure improves diastolic function and cardiac energy metabolism. Circ Heart Fail. 2015;8(1):128-37.
  73. Ahmet I., Tae H.J., Lakatta E.G., Talan M. Long-term low dose dietary resveratrol supplement reduces cardiovascular structural and functional deterioration in chronic heart failure in rats. Can J Physiol Pharmacol . 2017;95(3):268-74
  74. Roleda M.Y., Lütz-Meindl U., Wiencke C., Lütz C. Physiological, biochemical, and ultrastructural responses of the green macroalga Urospora penicilliformis from Arctic Spitsbergen to UV radiation. Protoplasma. 2010;243:105-16.
  75. Noroozi M., Amoozegar M.A. A survey on total carotenoids, chlorophyll a and b and also antioxidant activity of derived from four strain of green alga isolated from the Golestan coasts, (Caspian Sea). NCMBJ 2016;6(24):31-6.
  76. Ito Y., Kurata M., Suzuki K., Hamajima N., Hishida H., Aoki K. Cardiovascular disease mortality and serum carotenoid levels: a Japanese population-based follow-up study. J Epidemiol. 2006;16(4):154-60.
  77. Rajendran V., Pu Y., Chen B. An improved HPLC method for determination of carotenoids in human serum. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;824(1-2):99-106.
  78. Prakash S., Singh N., Priyatma V.S.K., Singh C. Assessment of mustard oil components against free radicals and oxidized LDL cholesterol. IJCS. 2019;7(3):423-8.
  79. Helmersson J., Ärnlöv J., Larsson A., Basu S. Low dietary intake of β-carotene, α-tocopherol and ascorbic acid is associated with increased inflammatory and oxidative stress status in a Swedish cohort. Br J Nutr. 2008;101(12):1775-82.
  80. Pashkow F.J., Watumull D.G., Campbell C.L. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am J Cardiol. 2008;101(10):S58-S68.
  81. Fuhrman B., Elis A., Aviram M. Hypocholesterolemic effect of lycopene and β-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages. Biochem Biophys Res Commun. 1997;233(3):658-62.
  82. Thies F., Mills L.M., Moir S., Masson L.F. Cardiovascular benefits of lycopene: fantasy or reality? Proc Nutr Soc. 2017;76(2):122-9.
  83. Dubois-Deruy E., Peugnet V., Turkieh A., Pinet F. Oxidative stress in cardiovascular diseases. Antioxidants. 2020;9(9):864.
  84. Senoner T., Dichtl W. Oxidative stress in cardiovascular diseases: still a therapeutic target? Nutrients. 2019;11(9):2090.
  85. He Q., Zhou W., Xiong C., Tan G., Chen M. Lycopene attenuates inflammation and apoptosis in post‑myocardial infarction remodeling by inhibiting the nuclear factor‑κB signaling pathway. Mol Med Rep. 2015;11(1):374-8.
  86. Omidyan R., Abedini F., Shahrokh L., Azimi G. Excited State Deactivation Mechanism in Protonated Uracil: New Insights from Theoretical Studies. J Phys Chem A. 2020;124(25):5089-97.
  87. Li F.J., Shen L., Ji H.F. Dietary intakes of vitamin E, vitamin C, and β-carotene and risk of Alzheimer's disease: a meta-analysis. J Alzheimers Dis. 2012;31(2):253-8.
  88. Santos-Sánchez N.F., Salas-Coronado R., Villanueva-Cañongo C., Hernández-Carlos B. Antioxidant compounds and their antioxidant mechanism. Antioxidants. 2019;10:1-29.
  89. Salvayre R., Negre-Salvayre A., Camaré C. Oxidative theory of atherosclerosis and antioxidants. Biochimie. 2016;125:281-96.
  90. Weber C., Erl W., Weber K., Weber P.C. Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation. 1996;93(8):1488-92.
  91. Uscio L.V., Milstien S., Richardson D., Smith L., Katusic Z.S. Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity. Circ Res. 2003;92(1):88-95.
  92. Khan S.U., Khan S.U., Suleman M., Khan M.U., Khan M.S., Arbi F.M., et al. Natural allies for heart health: Nrf2 Activation and cardiovascular disease management. Curr Probl Cardiol. 2024;49(1):102084.
  93. Bohn T., Bonet M.L., Borel P., Keijer J., Landrier J.F., Milisav I., et al. Mechanistic aspects of carotenoid health benefits–where are we now? Nutr Res Rev. 2021;34(2):276-302.
  94. Blaner W.S., Shmarakov I.O., Traber M.G. Vitamin A and vitamin E: will the real antioxidant please stand up? Annu Rev Nutr. 2021;41:105-31.
  95. Palace V.P., Hill M.F., Khaper N., Singal P.K. Metabolism of vitamin A in the heart increases after a myocardial infarction. Free Radic Biol Med. 1999;26(11-12):1501-7.
  96. Leigh R.S., Kaynak B.L. Vitamin A as a Transcriptional Regulator of Cardiovascular Disease. Hearts. 2020;1(2):126-45.
  97. Hajizadeh-Sharafabad F., Ghoreishi Z., Maleki V., Tarighat-Esfanjani A. Mechanistic insights into the effect of lutein on atherosclerosis, vascular dysfunction, and related risk factors: A systematic review of in vivo, ex vivo and in vitro studies. Pharmacol Res. 2019;149:104477.
  98. Zou Z., Xu X., Huang Y., Xiao X., Ma L., Sun T., et al. High serum level of lutein may be protective against early atherosclerosis: The Beijing atherosclerosis study. Atherosclerosis. 2011;219(2):789-93.
  99. Dilsiz N., Sahaboglu A., Yıldız M.Z., Reichenbach A. Protective effects of various antioxidants during ischemia-reperfusion in the rat retina. Graefes Arch Clin Exp Ophthalmol. 2006;244:627-33.
  100. Peng C.L., Lin Z.F., Su Y.Z., Lin G.Z., Dou H.Y., Zhao C.X. The antioxidative function of lutein: electron spin resonance studies and chemical detection. Funct Plant Biol. 2006;33(9):839-46.
  101. Jin X.H., Ohgami K., Shiratori K., Suzuki Y., Hirano T., Koyama Y., et al. Inhibitory effects of lutein on endotoxin-induced uveitis in Lewis rats. Invest Ophthalmol Vis Sci. 2006;47(6):2562-8.
  102. Ashino T., Yamanaka R., Yamamoto M., Shimokawa H., Sekikawa K., Iwakura Y. Negative feedback regulation of LPS-induced inducible NOS gene expression by HMOX-1 induction in macrophages. Mol Immunol. 2008;45:2106-15.
  103. Osganian S.K., Stampfer M.J., Rimm E., Spiegelman D., Manson J.E., Willett W.C. Dietary carotenoids and risk of coronary artery disease in women. Am J Clin Nutr. 2003;77(6):1390-9.
  104. Donhowe E.G., Kong F. Beta-carotene: digestion, microencapsulation, and in vitro bioavailability. Food Bioprocess Technol. 2014;7:338-54.
  105. Yang J., Zhang Y., Na X., Zhao A. β-Carotene supplementation and risk of cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials. Nutrients. 2022;14(6):1284.
  106. Jialal I., Norkus E.P., Cristol L., Grundy S.M. β-Carotene inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta. 1991;1086(1):134-8.
  107. Robbins M., Topol E.J. Inflammation in acute coronary syndromes. Acute coronary syndromes. 2001:1-31.
  108. Carvalho K.M., Benson R.F., Booth F.A., Collier M.J., Martin D.F. Analysis of commercial selenium-supplement tablets. Fla Sci. 2000:8-12.
  109. Raygan F., Behnejad M. Ostadmohammadi V., Bahmani F., Mansournia M.A., Karamali F., et al. Selenium supplementation lowers insulin resistance and markers of cardio-metabolic risk in patients with congestive heart failure: a randomised, double-blind, placebo-controlled trial. Br J Nutr. 2018;120(1):33-40.
  110. Vander-Pol A., Van-Gilst W.H., Voors A.A., Vander-Meer P. Treating oxidative stress in heart failure: past, present and future. Eur J Heart Fail. 2019;21(4):425-35.
  111. Frustaci A., Sabbioni E., Fortaner S., Farina M., del Torchio R., Tafani M., et al. Selenium‐and zinc‐deficient cardiomyopathy in human intestinal malabsorption: preliminary results of selenium/zinc infusion. Eur J Heart Fail. 2012;14(2):202-10.
  112. Lee B.C., Lee S.G., Choo M.K., Kim J.H., Lee H.M., Kim S., et al. Selenoprotein MsrB1 promotes anti-inflammatory cytokine gene expression in macrophages and controls immune response in vivo. Sci Rep. 2017;7(1):5119.
  113. Lee S.H., Lee S., Du J., Jain K., Ding M., Kadado A.J., et al. Mitochondrial MsrB2 serves as a switch and transducer for mitophagy. EMBO Mol Med. 2019;11(8):e10409.
  114. Verma S., Hoffmann F.W., Kumar M., Huang Z., Roe K., Nguyen-Wu.E., et al. Selenoprotein K knockout mice exhibit deficient calcium flux in immune cells and impaired immune responses. J Immunol. 2011;186(4):2127-37.
  115. Ma C., Hoffmann P.R. Selenoproteins as regulators of T cell proliferation, differentiation, and metabolism. Semin Cell Dev Biol. 2021:115:54-61.
  116. Walker A.M., Drozd M., Hall M., Patel P.A., Paton M., Lowry J., et al. Prevalence and predictors of sepsis death in patients with chronic heart failure and reduced left ventricular ejection fraction. J Am Heart Assoc 2018;7(20): 009684.
  117. Premer C., Kanelidis A.J., Hare J.M., Schulman I.H. Rethinking endothelial dysfunction as a crucial target in fighting heart failure. Mayo Clin Proc Innov Qual Outcomes. 2019;3(1):1-13.
  118. Junior E.L., Leite H.P., Konstantyner T. Selenium and selenoproteins: from endothelial cytoprotection to clinical outcomes. Transl Res. 2019;208:85-104.
  119. Huang Z., Rose A.H., Hoffmann P.R. The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2012;16(7):705-43.
  120. Stephens N.G., Parsons A., Brown M.J., Schofield P., Kelly F., Cheeseman K., et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347(9004):781-6.
  121. Fang J.C., Kinlay S., Beltrame J., Hikiti H., Wainstein M., Behrendt D., et al. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet. 2002;359(9312):1108-13.
  122. Siekmeier R., Steffen C., März W. [Can antioxidants prevent atherosclerosis?]. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2006;49(10):1034-49.
  123. Acheson R., Williams D. Does consumption of fruit and vegetables protect against stroke? 1983; 28;1(8335):1191-3
  124. Verlangieri A., Kapeghian J., El-Dean S., Bush M. Fruit and vegetable consumption and cardiovascular mortality. Med Hypotheses. 1985;16(1):7-15.
  125. Ginter E. Decline of coronary mortality in United States and vitamin C. Am J Clin Nutr. 1979;32(3):511-2.
  126. Gey K., Brubacher G., Stähelin H. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am J Clin Nutr. 1987;45: 368-77.
  127. Ramirez J., Flowers N. Leukocyte ascorbic acid and its relationship to coronary artery disease in man. Am J Clin Nutr. 1980;33(10):2079-87.
  128. Kok F., De-Bruijn A., Vermeeren R., Hofman A., Van Laar A., De Bruin M., et al. Serum selenium, vitamin antioxidants, and cardiovascular mortality: a 9-year follow-up study in the Netherlands. Am J Clin Nutr . 1987;45(2):462-8.
  129. Street D., Comstock G., Salkeld R, Schuep W., Klag M. A population-based case-control study of the association of serum antioxidants and myocardial infarction. Am J Epidemiol. 1991;134:719-20.
  130. Sianipar EA., Gunardi SI. Anti-inflammatory and antioxidant properties of Sargassum polycystum ethyl acetate extract from Indonesia. J Herbmed Pharmacol. 2023;12(3):407-412
  131. Ngai D.N., Kibiti C.M., Ngugi M.P. Spatial memory-enhancing effects and antioxidant activities of leaf and stem bark methanol extracts of Prunus africana in scopolamine-treated mice. J Herbmed Pharmacol. 2023;12(2):315-326.
آمار
تعداد مشاهده مقاله: 257
تعداد دریافت فایل اصل مقاله: 435


counter
سامانه مدیریت نشریات علمی. طراحی و پیاده سازی از سیناوب